Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3715_Библиотеки_им_академика_М_И_Перельмана
.pdf
References
https://t.me/medicina_free
113. Kyle RA, Gertz MA.Primary systemic amyloidosis: clinical and laboratory features in 474
cases. Semin Hematol. 1995;32(1):45–59.
114. Kim PN, Mitchell DG, Outwater EK.Budd-Chiari syndrome: hepatic venous obstruction by
an elevated diaphragm. Abdom Imaging. 1999;24:267–71.
115. Kumar SI, Kumar A, Srivastava S, Saraswat VA, Aggarwal R.Low frequency of factor V
Leiden and prothrombin G20210A mutations in patients with hepatic venous outow tract
obstruction in northern India: a case-control study. Ind J Gastroenterol. 2005;24:211–5.
116. Kiladjian JJ, Cervantes F, Leebeek FW, et al. The impact of JAK2 and MPL mutations
on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases. Blood.
2008;111(10):4835–6.
117. Kubo T, Shibata T, Itoh K, et al. Outcome of percutaneous transhepatic venoplasty for
hepatic venous outow obstruction after living donor liver transplantation. Radiology.
2006;239:285–90.
118. Kohli V, Pande GK, Dev V, Reddy KS, Kaul U, Nundy S.Management of hepatic venous
outow obstruction. Lancet. 1993;342:718–22.
119. Khuroo MS, Al-Suhabani H, Al-Sebayel M, etal. Budd-Chiari syndrome: long-term effect
on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol.
2005;20:1494–502.
120. Khuroo MS, Datta DV.Budd-Chiari syndrome following pregnancy. Report of 16 cases, with
roentgenologic, haemodynamic and histologic studies of the hepatic outow tract. Am J Med.
1980;68:113–21.
121. Kavanagh PM, Roberts J, Gibney R, Malone D, Hegarty J, McCormick PA.Acute BuddChiari syndrome with liver failure: the experience of a policy of initial interventional
radiological treatment using transjugular intrahepatic portosystemic shunt. J Gastroenterol
Hepatol. 2004;19:1135–9.
122. Kondur AK, Li T, Vaitkevicius P, etal. Quantication of myocardial iron overload by cardiovascular magnetic resonance imaging T2* and review of the literature. Clin Cardiol.
2009;32(6):E55–9.
123. Kumar S, Barbhaiya C, Nagashima K, Choi EK, Epstein LM, John RM, Maytin M, Albert
CM, Miller AL, Koplan BA, Michaud GF, Tedrow UB, Stevenson WG.Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of
catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:87–93. https://doi.org/10.1161/
CIRCEP.114.002145.
124. Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K,
Tuohinen S, Haataja P, Kerola T, Kokkonen J, Pelkonen M, Pietila-Effati P, Utrianen S,
Kupari M.Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in
a nationwide study. Circulation. 2015;131:624–32.
125. Ling LH, Oh JK, Breen JF, Schaff JV, Danielson GK, Mahoney DW, Seward JB, Tajik
AJ.Calcic constrictive pericarditis: is it still with us? Ann Intern Med. 2000;132:444–50.
126. Ludwig J, Hashimoto E, McGill D, Heerden JV. Classication of hepatic venous outow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc.
1990;65:51–5.
127. Ling LH, Oh JK, Schaff HV, Danielson GK, Mahoney OW, Seward JB, Tajik JA.Constrictive
pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100:1380–6.
128. Levine HD.Myocardial brosis in constrictive pericarditis electrocardiographic and pathologic observations. Circulation. 1973;48:1268–81.
129. Lisbona A, Katz S, Mishkin S.Serial radionuclide liver imaging in Budd-Chiari syndrome. J
Can Assoc Radiol. 1981;32:175–7.
130. Lee BB, Villavicencio L, Kim YW, etal. Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. J Vasc Surg. 2006;43:101–8.
131. Langlet P, Valla D.Is surgical portosystemic shunt the treatment of choice in Budd-Chiari
syndrome? Acta Gastroenterol Belg. 2002;65:155–60.
177
178
https://t.me/medicina_free
9 Diseases Mimicking Constrictive Pericarditis: Salient Features and Novel Strategies…
132. Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in
Budd-Chiari syndrome. J Hepatol. 2003;39:496–501.
133. Liang JJ, Hebl VB, DeSimone CV, Madhavan M, Nanda S, Kapa S, Maleszewski JJ, Edwards
WD, Reeder G, Cooper LT, Asirvatham SJ.Electrogram guidance: a method to increase the
precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and
myocarditis. JACC Heart Fail. 2014;2:466–73. https://doi.org/10.1016/j.jchf.2014.03.015.
134. Lu Y, Grant C, Xie K, Sweiss NJ.Suppression of myocardial 18F-FDG uptake through prolonged high-fat, high protein, and very low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. Clin Nucl Med. 2017;2(2):88–94.
135. McDermott WV, Stone MD, Bothe A, Trey C.Budd-Chiari syndrome: historical and clinical
review with analysis of surgical corrective procedures. Am J Surg. 1984;147:463–7.
136. Menu Y, Alison D, Lorphelin JM, Valla D, Belghiti J, Nahum H.Budd-Chiari syndrome: US
evaluation. Radiology. 1985;157:761–4.
137. Metras D. Endomyocardial brosis and its surgical treatment: Ivory Coast experience. In:
Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial brosis. New Delhi: Oxford
University Press; 1993. p.207–19.
138. Muchtar E, Blauwet LA, Gertz MA. Restrictive cardiomyopathy: genetics, pathogenesis,
clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121(7):819–37.
139. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M,
Marwick T, Nagueh SF, Sengupta PP, Sicari R.Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement
on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur
J Echocard. 2011;12(3):167–205.
140. MacGregor JH, Chen JT, Chiles C, Kier R, Godwin JD, Ravin CE.The radiographic distinction between pericardial and myocardial calcications. Am J Roentgenol. 1987;148(4):675–7.
141. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, Tomkowski WZ,
Thiene G, Yacoub MH, Priori SG, Alonso Garcia MA. Guidelines on the diagnosis and
management of pericardial diseases executive summary: the Task Force on the Diagnosis
and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart
J. 2004;25(7):587–610.
142. McCaughan BC, Schaff HV, Piehler JM, Danielson GK, Orszulak TA, Puga FJ, Pluth JR,
Connolly DC, McGoon DC.Early and late results of pericardiectomy for constrictive pericarditis. J Thorac Cardiovasc Surg. 1985;89(3):340–50.
143. Mocumbi AO, Ferreira MB, Sidi D, etal. A population study of endomyocardial brosis in a
rural area of Mozambique. N Engl J Med. 2008;359(1):43–9.
144. Mady C, Barreto ACP, de Oliveira SA, et al. Effectiveness of operative and non-operative
therapy in endomyocardial brosis. Am J Cardiol. 1989;63:1281–2.
145. Mullen DC, Dillon ML, Young WG, Sealy WC.Pericardiectomy in nontuberculous pericarditis. J Thorac Cardiovasc Surg. 1969;58:517.
146. Makuuchi M, Hasegawa H, Yamazaki S, et al. Primary Budd- Chiari syndrome: ultrasonic
demonstration. Radiology. 1984;1(52):775–9.
147. Mehrotra G, Singh RP, Krishna A, Singh BK.Pyogenic liver abscess causing acute BuddChiari syndrome. Ann Trop Paediatr. 1992;12:451–3.
148. Markert DJ, Shanmuganathan K, Mirvis SE, Nakajima Y, Hayakawa M. Budd-Chiari syndrome resulting from intrahepatic IVC compression secondary to blunt hepatic trauma. Clin
Radiol. 1997;52:384–7.
149. Mettler F.Essentials of nuclear medicine imaging. Orlando: Grune and Stratton; 1983. p.196.
150. Moss AA, Gamsu G, Genant HK.Computed tomogrpahy of the body. Philadelphia: Saunders;
1983. p.687–8.
151. Murphy FB, Steinberg HV, Shires GT, Martin LG, Bernardino ME.The Budd-Chiari syndrome: a review. AJR. 1986;147:9–15.
152. Murad SD, Valla DC, de Groen PC, etal. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004;39:500–8.
References
https://t.me/medicina_free
153. Murad SD, Valla DC, de Groen PC, etal. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol. 2006;101:83–90.
154. Martin LG, Henderson JM, Millikan WJ, Casarella WJ, Kaufman SL.Angioplasty for longterm treatment of patients with Budd-Chiari syndrome. Am J Roentgenol. 1990;154:1007–10.
155. Mishra TK, Routray SN, Behera M, Patnaik UK, Satapathy C.Percutaneous balloon angioplasty of membranous obstruction of the inferior vena cava. Indian Heart J. 2003;55:362–4.
156. McMullin MF, Hillmen P, Jackson J.Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. J Intern Med. 1994;235:85–9.
157. Molmenti EP, Segev DL, Arepally A, etal. The utility of TIPS in the management of BuddChiari syndrome. Ann Surg. 2005;241:978–81.
158. Meier WL III, WaIler RM III, Sones PJ Jr. Budd-Chiari web treated by percutaneous transluminal angioplasty. AJR. 1981;137:1257–8.
159. Muller-Quernheim J, Kienast K, Held M, et al. Treatment of chronic sarcoidosis with an
azathioprine/prednisolone regimen. Eur Respir J. 1999;14(5):1117–22.
160. Merlini G.AL amyloidosis: from molecular mechanisms to targeted therapies. Hematol Am
Soc Hematol Educ Program. 2017;2017(1):1–12.
161. Nagueh SF, Kopelen HA, Zoghbi WA.Relation of mean right atrial pressure to echocardiographic and Doppler parameters of right atrial and right ventricular function. Circulation.
1996;93(6):1160–9.
162. Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quiñones MA, Zoghbi WA.Doppler estimation of left ventricular lling pressure in sinus tachycardia: a new application of tissue
Doppler imaging. Circulation. 1998;98(16):1644–50.
163. Nagueh SF, Lakkis NM, Middleton KJ, Spencer WH III, Zoghbi WA, Quinones MA.Doppler
estimation of left ventricular lling pressures in patients with hypertrophic cardiomyopathy.
Circulation. 1999;99(2):254–61.
164. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA.Doppler tissue imaging:
a noninvasive technique for evaluation of left ventricular relaxation and estimation of lling
pressures. J Am Coll Cardiol. 1997;30(6):1527–33.
165. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left
ventricular diastolic function by echocardiography: an update from the American Society
of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc
Echocardiogr. 2016;29(4):277–314.
166. Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS. Haemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol.
2001;37(1):278–85.
167. Nair RR, Gupta PN, Valiathan MS, Kartha CC, Eapen JT, Nair NG.Enhanced cerium concentration in magnesium decient plants. Curr Sci. 1989;58:696–7.
168. Namboodiri N, Stiles MK, Young GD, etal. Electrophysiological features of atrial utter in
cardiac sarcoidosis: a report of two cases. Ind Pac Electrophysiol J. 2012;12(6):284–9.
169. Nery PB, Beanlands RS, Nair GM, etal. Atrioventricular block as the initial manifestion of
cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25(8):875–81.
170. Nagai S, Yokomatsu T, Tanizawa K, etal. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med. 2014;53(23):2761.
171. Nery PB, McArdle BA, Redpath CI, et al. Prevalence of cardiac sarcoidosis in patients
presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol.
2014;37(3):364–74.
172. Nishikawa M, Miyoshi S, Imai Y, etal. Treatment of the Budd- Chiari syndrome in polycythemia vera by repeated percutaneous transluminal angioplasty of a hepatic vein stenosis.
Postgrad Med J. 1982;58:511–4.
173. Nunez O, de la Cruz G, Molina J, etal. Interventional radiology, angioplasty and TIPS in
Budd-Chiari syndrome. Gastroenterol Hepatol. 2003;26:461–4.
174. Niederau CL, Fischer RU, Purschel A, etal. Long-term survival in patients with hereditary
hemochromatosis. Gastroenterology. 1996;110(4):1107–19.
179
180
https://t.me/medicina_free
9 Diseases Mimicking Constrictive Pericarditis: Salient Features and Novel Strategies…
175. Olsen EGJ.Morphological overview and pathogenetic mechanism in endomyocardial brosis associated with eosinophilia. In: Olsen EGJ, Sekiguchi M, editors. Cardiomyopathy
update3. Tokyo: University of Tokyo Press; 1990. p.1–8.
176. Oh JK, Hatle LK, Mulvagh SL, Tajik AJ.Transient constrictive pericarditis: diagnosis by
two-dimensional Doppler echocardiography. Mayo Clin Proc. 1993;68(12):1158–64.
177. de Oliveira SA, Barretto ACP, Mady C, etal. Surgical treatment ofendomyocardial brosis: a
new approach. J Am Call Cardiol. 1990;16:1246–51.
178. Olsen EGJ, Spry CJF.The pathogenesis of Loefer’s endomyocardial disease and its relationship to endomyocardial brosis. In: Yu P, Goodwin JF, editors. Progress in cardiology,
vol. 8. Philadelphia: Lea & Febiger; 1979. p.281–303.
179. Ohno S, Yoshimoto M, Honda S, etal. The antisense approach in amyloid light chain amyloidosis: identication of monoclonal Ig and inhibition of its production by antisense oligonucleotides in invitro and invivo models. J Immunol. 2002;169(7):4039–45.
180. Okuda K.Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy).
Semin Liver Dis. 2002;22:15–26.
181. Plessier A, Valla DC.Budd-Chiari syndrome. Semin Liver Dis. 2008;28(3):259–69.
182. Primignani M, Barosi G, Bergamaschi G, etal. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology.
2006;44:1528–34.
183. Patel RK, Lea NC, Heneghan MA, etal. Prevalence of the activating JAK2 tyrosine kinase
mutation V617F in the Budd-Chiari syndrome. Gastroenterology. 2006;130:2031–8.
184. Plessier A, Sibert A, Consigny Y, etal. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology. 2006;44(5):1308–16.
185. Pelage JP, Denys A, Valla D, etal. Budd-Chiari syndrome due to prothrombotic disorder:
mid-term patency and efcacy of endovascular stents. Eur Radiol. 2003;13:286–93.
186. Panis Y, Belghiti J, Valla D, Benhamou JP, Fekete F.Portosystemic shunt in Budd-Chiari
syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western
countries. Surgery. 1994;115:276–81.
187. Perello A, Garcia-Pagan JC, Gilabert R, etal. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology.
2002;35:132–9.
188. Qiao T, Liu CJ, Liu C, Chen K, Zhang XB, Zu MH.Interventional endovascular treatment
for Budd-Chiari syndrome with long-term follow-up. Swiss Med Wkly. 2005;135:318–26.
189. Reuss CS, Wilansky SM, Lester SJ, Lusk JL, Grill DE, Oh JK, etal. Using mitral ‘annulus
reversus’ to diagnose constrictive pericarditis. Eur J Echocardiogr. 2009;10:372–5.
190. Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation.
2012;126(10):1286–300.
191. Reisinger J, Dubrey SW, Lavalley M, etal. Electrophysiologic abnormalities in AL (Primary)
amyloidosis with cardiac involvement. J Am Coll Cardiol. 1997;30(4):1046–51.
192. Ryu RK, Durham JD, Krysl J, etal. Role of TIPS as a bridge to hepatic transplantation in
Budd-Chiari syndrome. J Vasc Interv Radiol. 1999;10:799–805.
193. Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari
syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt.
Surgery. 2004;135:394–403.
194. Roukoz H, Shah M, Masilamani LJ, etal. fQRS as a marker of granulomatous disease in
patients presenting with ventricular tachycardia and normal left ventricular ejection fraction.
Indian Heart J. 2015;67(3):222–6.
195. Roberts JT, Beck CS.The effect of chronic cardiac compression on the size of the heart
muscle bers. Am Heart J. 1941;22:314–20.
196. Rangheard AS, Vilgrain V, Audet P, et al. Focal nodular hyperplasia inducing hepatic vein
obstruction. AJR Am J Roentgenol. 2002;179:759–62.
197. Rahhal RM, Pashankar DS, Bishop WP.Ulcerative colitis complicated by ischemic colitis
and Budd-Chiari syndrome. J Pediatr Gastroenterol Nutr. 2005;40:94–7.
References
https://t.me/medicina_free
198. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic
study of 35 necropsy patients (group 1) and review of 78 previously described necropsy
patients (group 11). Am J Med. 1977;63:86–108.
199. Shaper AG. Cardiovascular disease in the tropics. II Endomyocardial brosis.
BMJ. 1972;3:743–6.
200. Shaper AG.The aetiology of endomyocardial brosis. In: Valiathan MS, Somers K, Kartha
CC, editors. Endomyocardial brosis. New Delhi: Oxford University Press; 1993. p.111–20.
201. Shrestha SM, Okuda K, Uchida T, etal. Endemicity and clinical picture of liver disease due to
obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol.
1996;11:170–9.
202. Sengupta P, Eleid MF, Sundt TM.Regional variability of pericardial thickness inuences left
ventricular diastolic recoil mechanics in constrictive pericarditis. J Am Soc Echocardiogr.
2008;21:518.
203. Sengupta PP, Eleid MF, Khandheria BK.Constrictive pericarditis. Circ J. 2008;72:1555–62.
204. Sengupta PP, Khandheria BK, Korinek J, Wang J, Jahangir A, Seward JB, etal. Apex-tobase dispersion in regional timing of left ventricular shortening and lengthening. J Am Coll
Cardiol. 2006;47:163–72.
205. Sengupta PP, Krishnamoorthy VK, Abhayaratna WP, etal. Disparate patterns oeft ventricular mechanics differentiate constrictive pericarditis from restrictive cardiomyopathy. JACC
Cardiovasc Imaging. 2008;1(1):29–38.
206. Sengupta PP, Krishnamoorthy VK, Abhayaratna WP, Korinek J, Belohlavek M, Sundt TM
3rd, etal. Comparison of usefulness of tissue Doppler imaging versus brain natriuretic peptide for differentiation of constrictive pericardial disease from restrictive cardiomyopathy.
Am J Cardiol. 2008;102:357.
207. Sengupta PP, Mohan JC, Mehta V, Arora R, Khandheria BK, Pandian NG.Doppler tissue
imaging improves assessment of abnormal interventricular septal and posterior wall motion
in constrictive pericarditis. J Am Soc Echocardiogr. 2005;18:226–30.
208. Sengupta PP, Mohan JC, Mehta V, Arora R, Pandian NG, Khandheria BK.Accuracy and
pitfalls of early diastolic motion of the mitral annulus for diagnosing constrictive pericarditis
by tissue Doppler imaging. Am J Cardiol. 2004;93:886–90.
209. Sengupta PP, Mohan JC, Mehta V, Jain V, Arora R, Pandian NG, etal. Comparison of echocardiographic features of noncompaction of the left ventricle in adults versus idiopathic
dilated cardiomyopathy in adults. Am J Cardiol. 2004;94:389–91.
210. Sengupta PP, Tajik AJ, Chandrasekaran K, Khandheria BK.Twist mechanics of the left ventricle: principles and application. JACC Cardiovasc Imaging. 2008;1:366–76.
211. Sankhyan LK, Yadav V, Sharma S, Choubey M, George N, Sushamagayatri B, Malik V,
Chowdhury UK.Assessment of myocardial mechanics in patients undergoing pericardiectomy for chronic constrictive pericarditis by tissue doppler imaging and 2D speckled tracking echocardiography: a prospective observational (Cohort) study. J Clin Cardiol Cardiovasc
Interv. 2021;4(3) https://doi.org/10.31579/2641- 0419/115.
212. Shabetai R, Fowler NO, Guntheroth WG.The haemodynamics of cardiac tamponade and
constrictive pericarditis. Am J Cardiol. 1970;26:480–9.
213. Shabetai R, Mangiardi L, Bhargava A, Ross J Jr, Higgins CB.The pericardium and cardiac
function. Prog Cardiovasc Dis. 1979;22:107–34.
214. Shabetai R. Controversial issues in restrictive cardiomyopathy. Postgrad Med
J. 1992;68:S47–51.
215. Shabetai R. Left ventricular function and myocardial contractility in chronic constrictive
pericarditis. Chest. 1971;59:476–7.
216. Shabetai R. Pathophysiology and differential diagnosis of restrictive cardiomyopathy.
Cardiovasc Clin. 1988;19:123–32.
217. Samuel I, Anklesaria X.Endomyocardial brosis in South India. Ind J Path Bact. 1960;3:157.
181
182
https://t.me/medicina_free
9 Diseases Mimicking Constrictive Pericarditis: Salient Features and Novel Strategies…
218. Schwefer M, Aschenbach R, Heidemann J, Mey C, Lapp H.Constrictive pericarditis, still
a diagnostic challenge: Comprehensivereview of clinical management. Eur J Cardiothorac
Surg. 2009;36:502–10.
219. Shapru RP.Clinical prole of EMG.ICMR workshop proceedings, 1981. In: Shapru RP, editor. EMG in India. Indian Council of Medical Research; 1983.
220. Shivakumar K, Appukuttan PS, Cc K.Interactions of thorium and cerium with adenine nucleotides. Biochem lnt. 1989;19:845–53.
221. Shivakumar K, Nair RR, Valiathan MS.Paradoxical effect of cerium on collagen synthesis in
cardiac broblasts. J Mol Cell Cardiol. 1992;24:775–80.
222. Seth S, Thatai D, Sharma S, etal. Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial brosis and idiopathic restrictive cardiomyopathy) in India. Eur J Heart
Fail. 2004;6(6):723–9.
223. Sasidharan K, Balakrishnan KG, Venkitachalam CG, Sapru RP. Radiological features of
endomyocardial brosis. Indian Heart J. 1980;32:234.
224. Sipe JD, Cohen AS.Review: history of the amyloid bril. J Struct Biol. 2000;130(2–3):88–98.
225. Sousa M, Monohan G, Rajagopalan N, etal. Heart transplantation in cardiac amyloidosis.
Heart Fail Rev. 2017;22(3):317–27.
226. Sachithanantham S, Wechalekar AD. Imaging in systemic amyloidosis. Br Med Bull.
2013;107:41–56.
227. Schwartz DJ, Thanavaro S, Kieiger RE, Krone RJ, Connors SP, Oliver CG.Epicardial pacemaker complicated by cardiac tamponade and constrictive pericarditis. Chest. 1979;76:226–7.
228. Stollberger C, Finsterer J.Extracardiac medical and neuromuscular implications in restrictive
cardiomyopathy. Clin Cardiol. 2007;30(8):375–80.
229. Srivastava PM, Burrell LM, Calaore P.Lateral vs medial mitral annular tissue Doppler in
the echocardiographic assessment of diastolic function and lling pressures: which should
we use? Eur J Echocardiogr. 2005;6:97–106.
230. Scholtz W, etal. Severe calcication of the latral mitral annulus in constrictive pericarditis: a
potential pitfall for the use of echocardiographic tissue Doppler imaging. Eur J Echocardiogr.
2008;9:403–5.
231. Sousa M, Manohan G, Rajagopalan N, etal. Heart treatment in cardiac amyloidosis. Heart
Fail Rev. 2017;22(3):317–27.
232. Sato M, Yamada R, Tsuji K, et al. Percutaneous transluminal angioplasty in segmental
obstruction of the hepatic inferior vena cava: long-term results. Cardiovasc Intervent Radiol.
1990;13:189–92.
233. Safka V, Hulek P, Krajina A, etal. Budd-Chiari syndrome and TIPS-twelve years’ experience.
Cas Lek Cesk. 2005;144(Suppl 3):38–42.
234. Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff SP.Pharmacological thrombolysis
in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol.
2004;40:172–80.
235. Srivatsa UN, Rogers J.Sarcoidosis and atrial brillation: a rare association and interlink with
inammation. Indian Pacing Electrophysiol J. 2012;12(6):290–1.
236. Slakey DP, Klein AS, Venbrux AC, Cameron JL.Budd-Chiari syndrome: current management options. Ann Surg. 2001;233:522–7.
237. Schoenfeld MH, Edwards WS, William GD Jr, etal. Restrictive cardiomyopathy versus constrictive pericarditis-role of endomyocardial biopsy in avoiding unnecessary thoracotomy.
Circulation. 1987;75:1012–7.
238. Tharakan JA.Electrocardiography in endomyocardial brosis. Indian Pacing Electrophysiol
J. 2011;11:129–33.
239. Tei C, Child JS, Tanaka H, Shah PM. Atrial systolic notch on the interventricular septal
echogram: an echocardiographic sign of constrictive pericarditis. J Am Coll Cardiol.
1983;1(3):907–12.
References
https://t.me/medicina_free
240. Talreja DR, Edwards WD, Danielson GK, Schaff HV, Tajik AJ, Tazelaar HD, Breen JF, Oh
JK.Constrictive pericarditis in 26 patients with histologically normal pericardial thickness.
Circulation. 2003;108:1852–7.
241. Tharakan JM, Venkatachalam CG, Balakrishnan KG. Angiographic features of endomyocardial brosis. In: Valiathan MS, editor. Endomyocardial Fibrosis. New Delhi: Oxford
University Press; 1993. p.168–84.
242. Talwar KK, Kumar V, Chopra P, etal. Endomyocardial biopsy study in patients with restrictive cardiomyopathy. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial
brosis. New Delhi: Oxford University Press; 1993. p.185–94.
243. Talwar KK, Narula JP, Chopra P.Myocarditis and myocardial interstitial brosis in constrictive pericarditis-an extended pathological spectrum. Int J Cardio1. 1990;29(2):241–3.
244. Tang TJ, Batts KP, de Groen PC, etal. The prognostic value of histology in the assessment of
patients with Budd-Chiari syndrome. J Hepatol. 2001;35:338–43.
245. Tavora F, Creswell N, Li L, etal. Comparison of necropsy ndings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am
J Cardiol. 2009;104:571–7.
246. Thachil A, Reddy S, Rao HB, etal. Subtle electrocardiographic ndings in idiopathic ventricular tachycardia- a malignant subset. Heart Rhythm. 2010;7(5):S196–257.
247. Tezuka D, Terashima M, Kato Y, Toriihara A, Hirasawa K, Sasaoka T, Yoshikawa S,
Maejima Y, Ashikaga T, Suzuki J, Hirao K, Isobe M.Clinical characteristics of denite or
suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging
and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
J Card Fail. 2015;21:313–22.
248. Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME.CT of hepatic morphologic changes in cirrhosis of the liver. J Comput Assist Tomogr. 1986;10:47–50.
249. Taguchi M, Ito Y, Shinohara S, et al. Successful management of BCS with PTA.Rinsho
Hoshasen. 1983;28:615–7.
250. Tavill AS, Wood EJ, Kreel L, Jones EA, Gregory M, Sherlock S. The Budd-Chiari syndrome: Correlation between hepatic scintigraphy and the clinical, radiological, and pathological ndings in nineteen cases of hepatic venous outow obstruction. Gastroenterology.
1975;68:509–18.
251. Tisnado J, Cho SR, Carithers J, Goldschmidt RA, Vines FS, Amendola M.The Budd-Chiari
syndrome: angiographic pathologic correlation. Radiographics. 1983;3:155–83.
252. Tyagi S, Jain BL, Kumar N, Lahoti D, Arora R.Balloon dilatation of inferior vena cava stenosis in Budd-Chiari syndrome. J Assoc Physicians India. 1996;44:378–80.
253. Uddin W, Ramage JK, Portmann B, etal. Hepatic venous outow obstruction in patients with
polycystic liver disease: pathogenesis and treatment. Gut. 1995;36:142–5.
254. Valiathan MS, Balakrishnan KG, Kartha CC.Endomyocardial brosis. In: Ahuja MMS, editor. Advances in clinical medicine. New Delhi: Churchill Livingstone; 1991. p.125–43.
255. Valiathan MS, Shyamkrishnan KG. Surgical treatment of endomyocardial brosis: Kerala
experience. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial brosis. New
Delhi: Oxford University Press; 1993. p.220–07.
256. Valla D. Hepatic venous outow tract obstruction etipathogenesis: Asia versus the West. J
Gastroenterol Hepatol. 2004;19:S204–11.
257. Voelkel AG, Pietro DA, Folland ED, Fisher ML, Parisi AF.Echocardiographic features of
constrictive pericarditis. Circulation. 1978;58:871–5.
258. Valla DC.Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis. 2002;22:5–14.
259. Veress G, Ling LH, Kim KH, Dal-Bianco JP, Schaff HV, Espinosa RE, Melduni RM, Tajik
JA, Sundt TM 3rd, Oh JK.Mitral and tricuspid annular velocities before and after pericardiectomy in patients with constrictive pericarditis. Circ Cardiovasc Imaging. 2011;4:399–407.
260. Verhaert D, Gabriel RS, Johnston D, Lytle BW, Desai MY, Klein AL.The role of multimodality imaging in the management of pericardial disease. Circ Cardiovasc Imaging.
2010;3:333–43.
183
184
https://t.me/medicina_free
9 Diseases Mimicking Constrictive Pericarditis: Salient Features and Novel Strategies…
261. Von Bibra H, Schober K, Jenni R, Busch R, Sebening H, Blomer H.Diagnosis of constrictive pericarditis by pulsed Doppler echocardiography of the hepatic vein. Am J Cardiol.
1989;63:483–8.
262. Valiathan MS, Kartha CC.Endomyocardial brosis-The possible connexion with myocardial
levels of magnesium and cerium. Int J Cardiol. 1990;28:1–5.
263. Valiathan MS, Kartha CC, Eapen JT, Dang HS, Sunta CM.A geochemical basis for endomyocardial brosis. Cardiovasc Res. 1989;23:647–8.
264. Venkatachalam CG, Balakrishanan KG, Tharakan JM.Echocardiographic ndings in endomyocardial brosis. In: Valiathan MS, editor. Endomyocardial brosis. New Delhi: Oxford
University Press; 1993. p.153–67.
265. Vita T, Okada DR, Veillet-Chowdhury M, etal. Complementary value of cardiac magnetic
resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018;11(1):e007030.
266. Valla DC.Prognosis in Budd Chiari syndrome after reestablishing hepatic venous drainage.
Gut. 2006;55:761–3.
267. Valla D, Hadengue A, el Younsi M, etal. Hepatic venous outow block caused by shortlength hepatic vein stenoses. Hepatology. 1997;25:814–9.
268. Valla D, Le MG, Poynard T, Zucman N, Rueff B, Benhamou JP.Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology.
1986;90:807–11.
269. Westermark P, Benson MD, Buxbaum IN, etal. A primer of amyloid nomenclature. Amyloid
Int J Exp Clin Invest. 2007;14(3):179–83.
270. Wechalekar AD, Schonland SO, Kastritis E, etal. A European collaborative study of treatment
outcomes in 346 patients with cardiac stage III AL amyloidosis. Blood. 2013;121(17):3420–7.
271. Wechalekar AD, Whelan C.Encouraging impact of doxycycline on early mortality in cardiac
light chain (AL) amyloidosis. Blood Cancer J. 2017;7(3):e546.
272. Witte AM, Kool LJ, Veenendaal R, Lamers CB, van Hoek B.Hepatic vein stenting for BuddChiari syndrome. Am J Gastroenterol. 1997;92:498–501.
273. Wu T, Wang L, Xiao Q, etal. Percutaneous balloon angioplasty of inferior vena cava in BuddChiari syndrome- R1. Int J Cardiol. 2002;83:175–8.
274. Wang SL, Sze DY, Busque S, et al. Treatment of hepatic venous outow obstruction after
piggyback liver transplantation. Radiology. 2005;236:352–9.
275. Xiaoming Z, Zhonggao W.Interventional or semi-interventional treatment for Budd-Chiari
syndrome. Chin Med Sci J. 2003;18:111–5.
276. Xu K, Feng B, Zhong H, etal. Clinical application of interventional techniques in the treatment of Budd-Chiari syndrome. Chin Med J. 2003;116:609–15.
277. Yazaki Y, Isobe M, Hiroe M, etal. Prognostic determinants of long-term survival in Japanese
patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88(9):1006–10.
278. Yodogawa K, Seino Y, Ohara T, etal. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16(2):140–7.
279. Young ID, Clark RN, Manley PN, Groll A, Simon JB.Response to steroids in Budd-Chiari
syndrome caused by idiopathic granulomatous venulitis. Gastroenterology. 1988;94:503–7.
280. Young JB, Leon CA, Short HD, Noon JP, Lawrence EC, Whisennand HH, etal. Evolution of
haemodynamics after orthotopic heart and heart-lung transplantation: Early restrictive patterns persisting in occult fashion. J Heart Transplant. 1987;6:34–43.
281. Yang XL, Cheng TO, Chen CR.Successful treatment by percutaneous balloon angioplasty
of Budd-Chiari syndrome caused by membranous obstruction of inferior vena cava: 8-year
follow-up study. J Am Coll Cardiol. 1996;28:1720–4.
282. Yamada A, Sato M, Kawabata M, Nakatsuka H, Nakamure K, Kobayashi N.Segmental
obstruction of the hepatic inferior vena cava treated by transluminal angioplasty. Radiology.
1983;1(49):91–6.
References
https://t.me/medicina_free
283. Yamada A, Tsumura M, Itami M, etal. Nonsurgically treated long segmental obstruction of
the hepatic IVC by means of TA using Gruentzig balloon catheter. Nippon Igaku Hoshasen
Gakkai Zasshi. 1981;41:101–7.
284. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Kobayashi N. Segmental
obstruction of the hepatic inferior vena cava treated by transluminal angioplasty. Radiology.
1983;149:91–6.
285. Zurick AO, Bolen MA, Kwon DH, Tan CD, Popovic ZB, Rajeswaran J, et al. Pericardial
delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis
undergoing surgical pericardiectomy: a case series with histopathological correlation. JACC
Cardiovasc Imaging. 2011;4:1180–91.
286. Zylberberg H, Valla D, Viguie F, Casadevall N.Budd-Chiari syndrome associated with 5q
deletion and hypereosinophilia. J Clin Gastroenterol. 1996;23:66–8.
287. Zeitoun G, Escolano S, Hadengue A, etal. Outcome of Budd-Chiari syndrome: a multivariate
analysis of factors related to survival including surgical portosystemic shunting. Hepatology.
1999;30:84–9.
288. Zhang CQ, Fu LN, Xu L, et al. Long-term effect of stent placement in 115 patients with
Budd-Chiari syndrome. World J Gastroenterol. 2003;9:2587–91.
185
Chapter 10
https://t.me/medicina_free
Denitions ofThe Extent ofPericardiectomy,
Echocardiographic Variables, Outcome
Variables, Haemodynamic Studies,
andNormal Acceptable Values
The following denitions of pericardial resection, echocardiographic variables, and
haemodynamic measures have been consistently used throughout this monograph in
order to maintain consistency with previous studies in the published literature.
When there are clinical features of constriction and supportive echocardiographic
and hemodynamic criteria, as previously outlined, constrictive pericarditis is
deemed to be of major haemodynamic importance.
In 2005, to dene the limit of pericardial resection, total pericardiectomy was
dened as wide excision of the pericardium with the phrenic nerves dening the
posterior extent, the great vessels including the intrapericardial portion of superior
caval vein and superior cavoatrial junction dening the superior extent, and the
diaphragmatic surface, including the inferior cavoatrial junction dening the inferior extent of the pericardial resection [4–12]. The atria and caval veins were decorticated in all cases in this study group, and constricting layers of the epicardium
were removed wherever possible. Pericardiectomy was considered partial if both
ventricles could not be decorticated completely because of dense myopericardial
adhesions or calcication [4–12]. The term “radical pericardiectomy” denes the
complete removal of the pericardium over the anterolateral, diaphragmatic surfaces
of the left ventricle, the portion of pericardium posterior to the phrenic nerve and the
left ventricle, and the anterior and diaphragmatic surfaces of the right ventricle until
the atrioventricular groove, leaving the left and right phrenic pedicles intact [4–11].
Subsequently, in 2020 for the sake of uniformity with other studies and suggestions of the Editorial Board of the Annals of Thoracic Surgery, we revised the denition of “total pericardiectomy” to include wide pericardial excisions over the
anterolateral, the diaphragmatic surfaces of both ventricles, the pericardium posterior to the phrenic nerve with intact phrenic pedicles, and over the great vessels,
including the intrapericardial cavoatrial junctions [12].
The term “partial pericardiectomy” is reserved for anything less than total pericardiectomy. In oncological conditions where draining lymphatics and lymph nodes
are also removed, the phrase “radical pericardiectomy” will be more specically
Ltd. 2023
U. K. Chowdhury, L. K. Sankhyan, Surgical Treatment of Chronic Constrictive
Pericarditis, https://doi.org/10.1007/978-981-99-5808-5_10
187© The Author(s), under exclusive license to Springer Nature Singapore Pte
Соседние файлы в папке Библиотека им академика М.И. Перельмана